Jeffrey Hung
Stock Analyst at Morgan Stanley
(0)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CGON CG Oncology | Maintains: Overweight | 52 56 | 25.96 | 115.72% | 4 | Jun 17, 2025 | |
ACAD ACADIA Pharmaceutica... | Maintains: Equal-Weight | 20 24 | 22.09 | 8.65% | 25 | May 20, 2025 | |
CTNM Contineum Therapeuti... | Maintains: Overweight | 25 20 | 4.15 | 381.93% | 3 | May 19, 2025 | |
RARE Ultragenyx Pharmaceu... | Maintains: Overweight | 64 65 | 36.51 | 78.03% | 8 | May 9, 2025 | |
JAZZ Jazz Pharmaceuticals | Maintains: Overweight | 183 166 | 107.03 | 55.1% | 6 | May 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 15 17 | 7.23 | 135.13% | 5 | May 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 37 34 | 3.66 | 828.96% | 3 | Mar 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 72 72 | 62.59 | 15.03% | 11 | Mar 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 67 70 | 49.79 | 40.59% | 11 | Mar 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 185 150 | 125.44 | 19.58% | 24 | Mar 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 4 4 | 1.29 | 210.08% | 3 | Mar 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 85 | 54.48 | 56.02% | 6 | Mar 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 38 35 | 7.76 | 351.03% | 6 | Mar 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 27 27 | 13.14 | 105.48% | 2 | Mar 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Underweight | 5 | 4.2 | 19.05% | 2 | Mar 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 70 67 | 33.16 | 102.05% | 13 | Feb 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 17 12 | 5.94 | 102.02% | 4 | Dec 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 92 95 | n/a | n/a | 5 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 35 | 6.24 | 460.9% | 1 | Jul 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 50 70 | 29.82 | 134.74% | 2 | May 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 295 330 | n/a | n/a | 3 | Dec 22, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 10 4 | 0.81 | 393.83% | 10 | Dec 19, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 13 4 | 7.94 | -49.62% | 1 | Dec 19, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 1 4 | 0.74 | 440.54% | 1 | Dec 19, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 60 140 | n/a | n/a | 1 | Dec 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 14 14 | 3.52 | 297.73% | 3 | Aug 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 5 5 | 2.7 | 85.19% | 1 | Jul 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 9 3 | 0.99 | 203.03% | 8 | Mar 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 15 14 | 1.39 | 907.19% | 7 | Feb 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 42 21 | n/a | n/a | 4 | Feb 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 4 2 | n/a | n/a | 3 | Feb 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 50 10 | 1.84 | 443.48% | 3 | Jan 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 22 30 | n/a | n/a | 6 | Jan 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 23 22 | 43.67 | -49.62% | 10 | Nov 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 2 2 | n/a | n/a | 5 | Sep 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 250 94 | n/a | n/a | 8 | Jul 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 146 149 | 14.07 | 955.44% | 2 | May 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 180 | n/a | n/a | 12 | Oct 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 100 60 | 1.68 | 3471.43% | 5 | Aug 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 6 | 2.96 | 102.7% | 9 | Apr 19, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 121 225 | n/a | n/a | 9 | Oct 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 58 54 | n/a | n/a | 6 | May 8, 2020 |